Ipratropium Nasal 0.03 and Moxetumomab Pasudotox-tdfk
Determining the interaction of Ipratropium Nasal 0.03 and Moxetumomab Pasudotox-tdfk and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ipratropium nasal
Brand name: Atrovent Nasal
Synonyms: Ipratropium nasal, Ipratropium (Nasal)
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ipratropium Nasal 0.03-Moxetumomab pasudotox-tdfk Intravenous
- Ipratropium Nasal 0.03-Moxifloxacin
- Ipratropium Nasal 0.03-Moxifloxacin (Systemic)
- Ipratropium Nasal 0.03-Moxifloxacin Hydrochloride
- Ipratropium Nasal 0.03-Moxifloxacin Injection
- Ipratropium Nasal 0.03-Moxifloxacin Intravenous
- Moxetumomab Pasudotox-tdfk-Ipratropium Nasal 0.06
- Moxetumomab Pasudotox-tdfk-Ipratrovent Sterules
- Moxetumomab Pasudotox-tdfk-Iprivask
- Moxetumomab Pasudotox-tdfk-IQ Dental Mepivacaine
- Moxetumomab Pasudotox-tdfk-Irbesartan
- Moxetumomab Pasudotox-tdfk-Irbesartan and Hydrochlorothiazide